Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06222840
Other study ID # IRBN662023/CHUSTE
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2023
Est. completion date October 31, 2023

Study information

Verified date July 2023
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

SYN1 gene mutation is an X-linked gene mutation that causes numerous pathological manifestations such as seizures and neurodevelopmental disorders. A few descriptions of this disease have been published in the last decade, but the electro-clinical features of epilepsy are still largely unknown. No analysis of electroencephalographic connectivity has yet been performed. The aim of this study is to perform a detailed electro-clinical seizure analysis and electroencephalographic analysis in patients with a SYN1 gene mutation, in an attempt to identify a characteristic pattern that would allow earlier diagnosis and better understanding and management of this disease.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date October 31, 2023
Est. primary completion date October 31, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Cases : SYN1 gene mutation, available electroencephalographic and clinical data. - Controls : older than 12 years at the moment of the electroencephalogram recording, electroencephalogram considered as normal, no neurological disease (particularly no epilepsy), no neuroimaging abnormality. Exclusion Criteria: - Controls : younger than 12 years at the moment of the electroencephalogram recording, electroencephalogram considered as abnormal, neurological disease (particularly epilepsy), neuroimaging abnormality.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Electro-clinical analysis of epileptic seizures
Electro-clinical analysis of epileptic seizures
Electro-encephalographic cases
Electro-encephalographic connectivity analysis compared to controls
Clinical datas analysis
Clinical datas analysis
Electro-encephalographic control
Electro-encephalographic connectivity analysis compared to cases

Locations

Country Name City State
France CHU Saint Etienne Saint-Étienne

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Electroencephalographic functional connectivity mapping Identify a characteristic electroclinical pattern in SYN1 gene mutation related epilepsy Month 6
Secondary Electroencephalographic reading grid Compare electro-encephalographic connectivity between SYN1 gene mutation patients and controls Month 6
See also
  Status Clinical Trial Phase
Recruiting NCT06223334 - Epileptic Syndromes in Infants and Early Childhood
Terminated NCT04639310 - XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy Phase 3
Terminated NCT04912856 - An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE Phase 3
Recruiting NCT04048213 - The Becoming of Children With Doose Syndrome